Press release
28 May 2026
Global biopharmaceutical leaders meet Japanese Prime Minister to reinforce action needed to retain Japan’s leadership in life‑sciences
28 MAY 2026, TOKYO – A delegation of over 20 global pharmaceutical leaders from top American, Japanese and European biopharmaceutical companies met this week with Prime Minister Sanae Takaichi to reinforce the action needed for Japan to grow its leadership in life sciences. Pharmaceutical industry amongst highest R&D intensive sectors in Japan Over the past...
Read more
Statement
23 May 2026
79th World Health Assembly (WHA79): Draft updated global action plan on antimicrobial resistance
On 23 May 2026, IFPMA delivered a statement on the draft updated Global Action Plan on antimicrobial resistance at the 79th session of the World Health Assembly in Geneva. We welcome the timely update of the Global Action Plan on AMR (GAP), which provides a unique opportunity to take stock of progress to date and...
Read more
Statement
23 May 2026
79th session of the World Health Assembly (WHA79): Harmonization of regulatory approaches, governance, and standards for data, digital health, and artificial intelligence in the health sector
On 23 May 2026, IFPMA delivered a statement on the harmonization of regulatory approaches, governance, and standards for data, digital health, and artificial intelligence in the health sector at the 79th session of the World Health Assembly in Geneva. Noting the previous work on digital health transformation, AI, and data governance, and the first WHO...
Read more
